Concepedia

Anti–IL-5 (mepolizumab) therapy for eosinophilic esophagitis

Miguel Stein, Joyce Villanueva, J P Kushner, Bridget K. Buckmeier, A. H. Filipovich, Amal Assa’ad

Journal of Allergy and Clinical Immunology · 2006 · 458 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response

Margaret J Leckie, Anneke Ten Brinke, Jamey Khan et al. · The Lancet · 2000 · 1.8K citations

, , +13

Eosinophilic Esophagitis: A 10-Year Experience in 381 Children

Chris A. Liacouras, Jonathan M. Spergel, Eduardo D. Ruchelli et al. · Clinical Gastroenterology and Hepatology · 2005 · 872 citations · Full text

, , +12

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis

Carine Blanchard · Journal of Clinical Investigation · 2006 · 862 citations · Full text

, , +13

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

Patrick Flood-Page, Andrew Menzies‐Gow, Simon Phipps et al. · Journal of Clinical Investigation · 2003 · 842 citations · Full text

, , +15

Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway

Patrick Flood-Page, Andrew Menzies‐Gow, A B Kay et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 809 citations

, , +15